Ralpancizumab Biosimilar – Anti-PCSK9, NARC1, PC9 mAb – Research Grade

Reference:
Size

,

Isotype

IgG2, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameRalpancizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb - Research Grade
SourceCAS 1407495-04-8
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsRalpancizumab,PF-05335810,RN317,PCSK9, NARC1, PC9,anti-PCSK9, NARC1, PC9
ReferencePX-TA1340
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody

Description of Ralpancizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb - Research Grade

General information on Anti-PCSK9/NARC1/ PC9[Homo sapiens] (Ralpancizumab) Monoclonal Antibody

Ralpancizumab has been investigated for the treatment of Hypercholesterolemia.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Ralpancizumab Biosimilar – Anti-PCSK9, NARC1, PC9 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human PCSK9 recombinant protein
Antigen

Human PCSK9 recombinant protein

PX-P5124 131$
PCSK9, C-His, recombinant protein
Antigen

PCSK9, C-His, recombinant protein

PX-P5877 500$
Human IgG2 Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG2 Isotype Control antibody (HyHEL-10)

PTX17900 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products